Currently, HIV infection is not curable, but infected individuals can manage their condition by taking daily doses of antiretroviral therapy. Some individuals, known as elite controllers (ECs), are bo
Data from Diagnoses Form: Category A [CRF 2; category A diagnoses table] Study Description A Phase II, open-label, multi-center study that evaluated the immunogenicity, safety, tolerability, and behav
Different HIV/SIV vaccine vectors expressing the same viral antigens can elicit disparate T-cell responses. Within this spectrum, replicating variable vaccines like SIVmac239?nef appear to generate pa
